Rapport Therapeutics, Inc. (RAPP) stock
RAPPNasdaqPharmaceutical PreparationsFiscal year ends December 31
$23.76−1.06 (-4.27%)
Close on Nov 17, 2026Market cap $1.14BP/E –Yield –
Rapport Therapeutics market cap
Market capitalization is the share price multiplied by the number of shares outstanding.
Rapport Therapeutics's market cap was $1.30B on Nov 11, 2026, against $1.42B a year earlier. Over the last 3 years it ranged from $94.76M to $2.33B, with a median of $1.06B.
Market Cap at the end of each year
| Period | Period end | Value | Change |
|---|---|---|---|
| 2026 | Nov 11, 2026 | $1.30B | -10.4% |
| 2025 | Dec 31, 2025 | $1.45B | +122.8% |
| 2024 | Dec 31, 2024 | $648.87M | – |
See a number that looks wrong?